Le Lézard
Classified in: Science and technology, Business
Subjects: AWD, SLS

FINBOA Demonstrates Solid Growth in 3Q 2022


Fintech acquires 16 new customers and is ranked #11 on HBJ Fast 100 List

HOUSTON, Oct. 14, 2022 /PRNewswire/ -- FINBOA, Inc., a leading innovator in intelligent process automation for regulatory compliance in financial institutions, welcomed 16 new financial institutions during the third fiscal quarter ending September 30, 2022. In addition to an expanded customer base, FINBOA experienced a 92% increase in revenue growth in 3Q 2022 over the same period 2021.

FINBOA was recently awarded 11th place on the 2022 Houston Business Journal (HBJ) Fast 100 List. This list recognizes Houston-area private companies with the fastest revenue growth over a two year period. FINBOA secured their ranking with over 300% revenue growth from 2019 through 2022. 

FINBOA attributes their continued success to offering a proven portfolio of SaaS software solutions specifically designed for banks and credit unions to transform complex back-office processing and the customer experience using digitization and Robotic Process Automation.  FINBOA increases staff efficiency and accuracy, while reducing compliance costs, loss and risk.

FINBOA CEO and Founder, Raj Singal commented, "We've had great success with our solutions and plan to continue to grow the business with a focus on serving our customers well and maintaining our current product and industry focus. We have been able to leverage our deep expertise to help institutions with their transition to fully digital operations. We are actively expanding our current offerings, and developing new solutions, which will accelerate our growth."

FINBOA's industry recognized SaaS products digitize and modernize the inefficient manual processes and disparate systems commonly used to manage regulatory compliance processing for Payment Disputes, Loan Onboarding, Exception Management, Wires and Treasury Onboarding.

FINBOA partners with customers to ensure successful implementation and solution adoption. Account retention remains high as FINBOA users experience real results. For example, FINBOA's Regulation E Payment Dispute solution reduces claim-related losses up to 25% and process time by 90%, with an average implementation timeline of less than 60 days. 

About FINBOA
FINBOA provides intelligent process automation to banks and credit unions to simplify and improve regulatory compliance by eliminating manual systems. Leveraging extensive industry experience and a commitment to customer service, FINBOA delivers transformative software  proven to enable institutional growth by reducing operational costs and risk. FINBOA is headquartered in Houston. Learn more at www.finboa.com or follow us on LinkedInFacebook and Twitter.

SOURCE FINBOA


These press releases may also interest you

at 03:30
Amflow, the eMTB expert that builds e-bikes from heart to body, today marks its entry into the industry with the launch of the Amflow PL. Providing a significantly robust 850 W of peak power and weighing in at an industry leading level of ultra-light...

at 03:17
Daniels Manufacturing Corporation® (DMC®) is proud to announce the successful acquisition of MCD-Tools GmbH, a leading tool distribution and repair company based near Frankfurt, Germany. DMC's acquisition of MCD-Tools allows DMC to form DMC Europe...

at 03:05
NielsenIQ (NIQ) today announced the availability of NIQ Activate in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. NIQ customers can now take advantage of the productive and trusted Azure cloud...

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
Manhattan Associates today announced that it has been named winner of the VIP Awards' Best Sustainability Initiative category for 2024. Selected from a competitive group of nominees, Manhattan Active® Supply Chain technology was chosen because of...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...



News published on and distributed by: